WHO ICTRP trial
Alprostadil versus isosorbide dinitrate in ameliorating angina episodes in…
ChiCTR2000033233 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000033233 |
|---|---|
| Public title | Alprostadil versus isosorbide dinitrate in ameliorating angina episodes in patients with coronary slow flow phenomenon |
| Scientific title | Alprostadil versus isosorbide dinitrate in ameliorating angina episodes in patients with coronary slow flow phenomenon |
| Primary sponsor | Shanghai Chest Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | coronary slow flow phenomenon |
| Interventions | Alprostadil group:Oral alprostadil (40 µg/tablet, three times per day);isosorbide dinitrate group:isosorbide dinitrate (5 mg/tablet, three times per day) |
| Registration date | May 25, 2020 |
| Target size | Alprostadil group:30;isosorbide dinitrate group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: